References
- Bae JH, Bassenge E, Kim MH et al. Impact of left ventricular ejection fraction on endothelial function in patients with coronary artery disease. Clin. Cardiol.27(6), 333–337 (2004).
- Ludmer PL, Selwyn AP, Shook TL. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med.315(17), 1046–1051 (1986).
- Felmeden DC, Blann AD, Spencer CG et al. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo–Scandinavian Cardiac Outcomes Trial. Blood Coagul. Fibrinolysis14(5), 425–431 (2003).
- Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol.49(7), 741–752 (2007).
- Goon PK, Boos CJ, Stonelake PS et al. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb. Haemost.96(1), 45–52 (2006).
- Dwivedi G, Janardhanan R, Hayat SA et al. Prognostic value of myocardial viability detected by myocardial contrast echocardiography early after acute myocardial infarction. J. Am. Coll. Cardiol.50(4), 327–334 (2007).
- Xu JZ, Zhang Y, Wu SN et al. Impaired endothelial function in hypertensive patients with target organ damage. J. Hum. Hypertens. DOI: 10.1038/jhh.2009.10 (2009) (Epub ahead of print).
- Hare JM, Nguyen GC, Massaro AF et al. Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure. J. Am. Coll. Cardiol.40(6), 1114–1119 (2002).
- Libby P. Inflammation in atherosclerosis. Nature420(6917), 868–874 (2002).
- Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol.25(2), 9–12 (1995).
- Perticone F, Ceravolo R, Pujia A et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation104(2), 191–196 (2001).
- Iida M, Nihei M, Yamazaki M et al. Predictive value of von Willebrand factor for adverse clinical outcome in hypertensive patients with mild-to-moderate aortic regurgitation. J. Hum. Hypertens.22(4), 275–281 (2008).
- Juhan-Vague I, Pyke SD, Alessi MC et al. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation94(9), 2057–2063 (1996).
- Passoni F, Morelli B, Seveso G et al. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes. Ital. Heart. J.3(1), 28–33 (2002).
- Karatzis EN, Ikonomidis I, Vamvakou GD et al. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am. J. Cardiol.98(11), 1424–1428 (2006).
- Heitzer T, Baldus S, von Kodolitsch Y, Rudolph V, Meinertz T. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler. Thromb. Vasc. Biol.25(6), 1174–1179 (2005).
- Michowitz Y, Goldstein E, Wexler D, Sheps D, Keren G, George J. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart93(9), 1046–1050 (2007).
- Ferrari R, Fox K. Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate ‘EUROPA’ story. Drugs69(3), 265–277 (2009).
- Ostad MA, Eggeling S, Tschentscher P et al. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. Atherosclerosis DOI: 10.1016/j.atherosclerosis.2008.11.032 (2008) (Epub ahead of print).